Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate
- 28 February 1981
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 7 (4-5), 305-310
- https://doi.org/10.1016/0378-4274(81)90053-9
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrateJournal of Toxicology and Environmental Health, 1980
- Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogensNature, 1980
- In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesisMutation Research/Reviews in Genetic Toxicology, 1979
- Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-α-p-chlorophenoxyisobutyrate (clofibrate) in ratsBritish Journal of Cancer, 1979
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978
- Time course of the induction of aryl hydrocarbon hydroxylase in rat liver nuclei and microsomes by phenobarbital, 3-methylcholanthrene, 2,3,7,8-tetrachloro-dibenzo-p-dioxin, dieldrin and other inducersBiochemical Pharmacology, 1978
- Hepatic Peroxisome Proliferation: Induction by Two Novel Compounds Structurally Unrelated to ClofibrateScience, 1975
- Hydroxyapatite column chromatography in procedures for isolation of purified DNAAnalytical Biochemistry, 1974
- Drugs and Lipid MetabolismAnnual Review of Pharmacology, 1973
- NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RATNature, 1965